N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
US4568687A · kind A · utility
13Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 1984 |
| Grant date | Feb 4, 1986 |
| Priority date | — |
| Expiry date | Jan 13, 2004 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D249/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure describes novel N-[.omega.-(1H-imidazol-1-yl)alkyl]arylamides which possess the property of inhibiting the enzyme thromboxane synthetase and are also useful in the treatment of hypertension and myocardial ischemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.